Pharmacology and Therapeutics

Immune modulating drug MP1032 with SARS-CoV-2 antiviral activity in vitro: A potential multi-target approach for prevention and early intervention treatment of COVID-19
Sara Schumann, Astrid Kaiser, Ferdinando Nicoletti, Katia Mangano, Paolo Fagone, Eduard van Wijk, Yu Yan, Petra Schulz, Beate Ludescher, Michael Niedermaier, Joerg von Wegerer, Pia Rauch, Christian Setz, Ulrich Schubert, Wolfgang Brysch

medRxiv 2020.11.03.20216580; doi: https://doi.org/10.1101/2020.11.03.20216580

Add to Selected Citations
Plasma concentration and safety of lopinavir/ritonavir in patients with Covid-19: a short communication
Laurent Chouchana, Sana Boujaafar, Ines Gana, Laure-Hélène, Lucile Regard, Paul Legendre, Celia Azoulay, Etienne Canouï, Jeremie Zerbit, Nicolas Carlier, Benjamin Terrier, Solen Kernéis, Rui Batista, Jean-Marc Treluyer, Yi Zheng, Sihem Benaboud

medRxiv 2020.05.18.20105650; doi: https://doi.org/10.1101/2020.05.18.20105650

Add to Selected Citations
In Vivo Mitochondrial ATP Production Is Improved in Older Adult Skeletal Muscle After a Single Dose of Elamipretide in a Randomized Trial
Baback Roshanravan, Sophia Z. Liu, Eric G. Shankland, John K. Amory, H. Thomas Robertson, David J. Marcinek, Kevin E. Conley

medRxiv 2020.09.30.20200493; doi: https://doi.org/10.1101/2020.09.30.20200493

Add to Selected Citations
A wake-up call - revealing the oversight of sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants
Okko Alitalo, Roosa Saarreharju, Carlos A. Zarate Jr, Samuel Kohtala, Tomi Rantamäki

medRxiv 2020.09.29.20204008; doi: https://doi.org/10.1101/2020.09.29.20204008

Add to Selected Citations
Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
Leticia R. Cruz, Idania Baladrón, Aliusha Rittoles, Pablo A. Díaz, Carmen Valenzuela, Raúl Santana, Maria M. Vázquez, Ariadna García, Deyli Chacón, Delvin Thompson, Gustavo Perera, Ariel González, Rafael Reyes, Loida Torres, Jesus Pérez, Yania Valido, Ralysmay Rodriguez, Dania M. Vázquez, Mauro Rosales, Ailyn C. Ramón, George V. Pérez, Gerardo Guillén, Verena Muzio, Yasser Perera, Silvio E. Perea, for the ATENEA-Co-300 group

medRxiv 2020.09.03.20187112; doi: https://doi.org/10.1101/2020.09.03.20187112

Add to Selected Citations
Validated ICP-MS method for measurement of plasma and intracellular antimony concentrations applied to pharmacokinetics of meglumine antimoniate
Diana J. Garay-Baquero, David E. Rebellon-Sánchez, Miguel D. Prieto, Lina Giraldo-Parra, Adriana Navas, Sheryl Atkinson, Stuart McDougall, Maria Adelaida Gómez

medRxiv 2020.09.15.20194647; doi: https://doi.org/10.1101/2020.09.15.20194647

Add to Selected Citations
External validation of the predictive performance of population pharmacokinetic models for phenobarbital in pediatric patients
Sunae Ryu, Woo Jin Jung, Zheng Jiao, Jung-Woo Chae, Hwi-yeol Yun

medRxiv 2020.09.10.20192005; doi: https://doi.org/10.1101/2020.09.10.20192005

Add to Selected Citations
Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing
Zhe Tang, Jing Guan, Jingjing Li, Yanxia Yu, Miao Qian, Jiang Cao, Weiwei Shuai, Zheng Jiao

medRxiv 2020.03.30.20045971; doi: https://doi.org/10.1101/2020.03.30.20045971

Add to Selected Citations
Association of nocebo hyperalgesia and basic somatosensory characteristics in a large cohort
Mari Hanna Feldhaus, Björn Horing, Christian Sprenger, Christian Büchel

medRxiv 2020.09.08.20190728; doi: https://doi.org/10.1101/2020.09.08.20190728

Add to Selected Citations
Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs
Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali, Jacques Turgeon

medRxiv 2020.04.21.20066761; doi: https://doi.org/10.1101/2020.04.21.20066761

Add to Selected Citations

Pharmacology and Therapeutics

Pages